NanoViricides Inc. (NNVC)

[arvitar]

And yet, there is a complete absence of concern over "backing up facts" when it comes to the stream golden truth flowing forth from Seymour's lips...

Go figure....

NanoViricides, Inc is a well-funded nanobiotechnology company that trades on the NYSE. We have developed a platform technology that allows us to create an new anti-viral drug in approximately 8 weeks. we have 10 drugs in our pipeline. These include treatments for HIV, dengue, dengue hemorrhagic fever, rabies, influenza, adenovirus and herpes of the eye, as well as topical treatments for shingles, cold sores and genital herpes. We have over 30 scientists working at our recently opened, state-of-the-art production facility in Connecticut. Our drugs have been tested in over 6,000 animals without a therapeutic failure, side effects or evidence of toxicity. Our collaborators include universities, medical and veterinary schools, military research organizations, non-profit research centers as well as hospitals. We are currently engaged in IND-enabling studies on our eye drops for the treatment of herpetic keratitis, the most common cause of infectious blindness in the developed world. We have previously presented at both BIO and BIOCEO
https://ceo16.eventsbio.com/connect/sessionDetail.ww?SESSION_ID=12743